This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (52) Citing Articles via Google Scholar Google Scholar Articles by McMurray, J. Articles by Ford, I. Search for Related Content PubMed PubMed Citation Articles by McMurray, J. Articles by Ford, I. Related Collections Related Article

Antiarrhythmic effect of carvedilol after acute myocardial infarction

Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial

John McMurray, MD^*,*, Lars Køber, MD, Michele Robertson, BSc, Henry Dargie, MB, ChB^*, Wilson Colucci, MD, Jose Lopez-Sendon, MD^||, Willem Remme, MD^¶, D. Norman Sharpe, MD^# and Ian Ford, PhD

^* Department of Cardiology, Western Infirmary, Glasgow, United Kingdom
Department of Cardiology, Gentoffe University Hospital, Copenhagen, Denmark
Robertson Centre for Biostatistics, University of Glasgow; Glasgow, United Kingdom
Boston University Medical Center, Boston, Massachusetts
^|| Department of Cardiology, Hospital University, Madrid, Spain
^¶ Sticares Foundation, Rhoon, the Netherlands
^# Department of Medicine, University of Auckland, Auckland, New Zealand

View larger version (8K): [in a new window]   Figure 1 Survival free of atrial fibrillation or atrial flutter. Dotted line = placebo; solid line = carvedilol.

View larger version (9K): [in a new window]   Figure 2 Survival free of any ventricular arrhythmia. Dotted line = placebo; solid line = carvedilol.